EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

PSC-specific prognostic scores associated with graft loss and overall mortality in recurrent PSC after liver transplantation

Ellina Lytvyak, Dennis Wang, Devika Shreekumar, Maryam Ebadi, Yousef Alrifae, Andrew Mason, Aldo J Montano-Loza

Digestive and Liver Disease · 2025

DOI: 10.1016/j.dld.2025.02.001 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Digestive and Liver Disease, 2025. Verfasst von Ellina Lytvyak und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Preventive Medicine, Department of Medicine, University of Alberta, 5-30 University Terrace, 8303 112 Street, Edmonton, Alberta T6G 2T4, …. Hauptthemen laut MEDLINE: Liver Transplantation, Cholangitis, Sclerosing, Graft Rejection. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Primary sclerosing cholangitis (PSC) is a progressive liver disease with no treatment apart from liver transplantation (LT). After LT, patients can develop recurrent PSC (rPSC). The United-Kingdom (UK-PSC) and Amsterdam-Oxford (AOPSC) scores are used as prognostic models for PSC outcomes. AIM: We aimed to assess these scores as predictive tools for graft loss and overall mortality in rPSC. METHODS: We evaluated 67 people who developed rPSC. Using Cox regression models, we quantified associations between UK-PSC and AOPSC scores and graft loss and overall mortality. Cut-offs were established using receiver operator characteristic analysis and the highest Youden index. RESULTS: Fifty-one individuals (76.1%) were males, with a mean age of 40±15 years. Both UK-PSC and AOPSC scores were independently associated with graft loss (hazard ratio [HR] 2.43 (p < 0.001) and HR 3.45 (p < 0.001), respectively), but only the UK-PSC score was independently associated with overall mortality (HR 2.63 (p = 0.009)). Individuals with UK-PSC ≥-4.2 (6.1 ± 0.8 vs. 14.7 ± 1.0 years; p = 0.001) and AOPSC ≥2.4 (5.4 ± 1.3 vs. 12.0 ± 1.1 years; p < 0.001) had shorter graft survival. CONCLUSION: UK-PSC score at rPSC predicts both graft loss and overall mortality, while AOPSC scores using either age at rPSC or at diagnosis along with severe cholestasis predict graft loss in people with rPSC. These easy-to-administer tools can be utilized in clinical practice to identify high-risk rPSC patients and guide decisions about monitoring/interventions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver TransplantationCholangitis, SclerosingGraft RejectionHumansMaleFemaleAdultMiddle AgedPrognosisRecurrenceProportional Hazards ModelsGraft SurvivalRetrospective StudiesUnited KingdomROC CurveSeverity of Illness Index

Stichwörter der Autor:innen

Autoimmune liver diseasesPrimary sclerosing cholangitisPrognosisPrognostic indexRecurrence

Autor:innen und Institutionen

  • Division of Preventive Medicine, Department of Medicine, University of Alberta, 5-30 University Terrace, 8303 112 Street, Edmonton, Alberta T6G 2T4, Canada. Electronic address: lytvyak@ualberta.ca.
  • Division of Gastroenterology & Liver Unit, Department of Medicine, University of Alberta, 8540 112 Street NW, Zeidler Ledcor Centre, Room 1-20B, Edmonton, Alberta T6G 2×8, Canada. Electronic address: dennis2@ualberta.ca.
  • Division of Gastroenterology & Liver Unit, Department of Medicine, University of Alberta, 8540 112 Street NW, Zeidler Ledcor Centre, Room 1-20B, Edmonton, Alberta T6G 2×8, Canada. Electronic address: shreekum@ualberta.c…
  • Division of Gastroenterology & Liver Unit, Department of Medicine, University of Alberta, 8540 112 Street NW, Zeidler Ledcor Centre, Room 1-20B, Edmonton, Alberta T6G 2×8, Canada. Electronic address: ebadi@ualberta.ca.
  • Division of Gastroenterology & Liver Unit, Department of Medicine, University of Alberta, 8540 112 Street NW, Zeidler Ledcor Centre, Room 1-20B, Edmonton, Alberta T6G 2×8, Canada. Electronic address: alrifae@ualberta.ca.
  • Division of Gastroenterology & Liver Unit, Department of Medicine, University of Alberta, 8540 112 Street NW, Zeidler Ledcor Centre, Room 1-20B, Edmonton, Alberta T6G 2×8, Canada. Electronic address: andrew.mason@ualber…

Zitieren

APA

Lytvyak, E., Wang, D., Shreekumar, D., Ebadi, M., Alrifae, Y., Mason, A., & Montano-Loza, A. J. (2025). PSC-specific prognostic scores associated with graft loss and overall mortality in recurrent PSC after liver transplantation. Digestive and Liver Disease. https://doi.org/10.1016/j.dld.2025.02.001

Vancouver

Lytvyak E, Wang D, Shreekumar D, Ebadi M, Alrifae Y, Mason A, et al. PSC-specific prognostic scores associated with graft loss and overall mortality in recurrent PSC after liver transplantation. Digestive and Liver Disease. 2025. doi:10.1016/j.dld.2025.02.001

BibTeX
@article{Lytvyak2025,
  author = {Lytvyak, Ellina and Wang, Dennis and Shreekumar, Devika and Ebadi, Maryam and Alrifae, Yousef and Mason, Andrew and Montano-Loza, Aldo J},
  title = {PSC-specific prognostic scores associated with graft loss and overall mortality in recurrent PSC after liver transplantation},
  journal = {Digestive and Liver Disease},
  year = {2025},
  doi = {10.1016/j.dld.2025.02.001}
}
Kostenlos starten →